Science Explorer Back to mapMap

Most cited papers from Clearside Biomedical (United States)

What are the most cited papers from Clearside Biomedical (United States)?

The most cited paper from Clearside Biomedical (United States) is "Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis" (Steven Yeh, Rahul N. Khurana, Milan Shah et al., 2020), with 188 citations. Next come "Treatment of Acute Posterior Uveitis in a Porcine Model by Injection of Triamcinolone Acetonide Into the Suprachoroidal Space Using Microneedles" (155) and "Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates" (147).

Showing 50 of 59 papers. Every paper with more than 9 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis Steven Yeh, Rahul N. Khurana, Milan Shah et al. · Ophthalmology Open access 10 Jan 2020 188
2 Treatment of Acute Posterior Uveitis in a Porcine Model by Injection of Triamcinolone Acetonide Into the Suprachoroidal Space Using Microneedles Brian C. Gilger, Eva M. Abarca, Jacklyn H. Salmon et al. · Investigative Ophthalmology & Visual Science 26 Mar 2013 155
3 Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates Glenn C. Yiu, Sook Hyun Chung, Iris Natalie Mollhoff et al. · Molecular Therapy — Methods & Clinical Development Open access 20 Jan 2020 147
4 Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study Peter A. Campochiaro, Charles C. Wykoff, David M. Brown et al. · Ophthalmology Retina 29 Sep 2017 115
5 Innovative therapies for neovascular age-related macular degeneration Hasenin Al-khersan, Rehan M. Hussain, Thomas A. Ciulla et al. · Expert Opinion on Pharmacotherapy 12 Jul 2019 114
6 Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease Rehan M. Hussain, Ashley E. Neiweem, Viral S. Kansara et al. · Expert Opinion on Investigational Drugs 12 Sep 2019 112
7 Prevalence and characteristics of smokers at 30 Pacific Northwest colleges and universities Beti Thompson, Gloria D. Coronado, Lu Chen et al. · Nicotine & Tobacco Research 2007 107
8 Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment Sameer P. Leley, Thomas A. Ciulla, Ashay Dilip Bhatwadekar · Clinical Interventions in Aging Open access Jul 2021 100
9 Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis Debra Anne Goldstein, Diana Do, Glenn Noronha et al. · Translational Vision Science & Technology Open access 14 Dec 2016 92
10 Suprachoroidally injected pharmacological agents for the treatment of chorio‐retinal diseases: a targeted approach Zohar Habot‐Wilner, Glenn Noronha, Charles C. Wykoff · Acta Ophthalmologica 31 Jan 2019 87
11 Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases Viral S. Kansara, Leroy W. Muya, Chen-rei Wan et al. · Journal of Ocular Pharmacology and Therapeutics Open access 7 Apr 2020 83
12 Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care forRPE65-Mediated Inherited Retinal Disease Scott J. Johnson, Marric Buessing, Thomas O’Connell et al. · JAMA Ophthalmology Open access 18 Jul 2019 80
13 SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS Steven Yeh, Shree K. Kurup, Robert C. Wang et al. · Retina 16 Aug 2018 76
14 Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World Ashay Dilip Bhatwadekar, Aumer Shughoury, Ameya Belamkar et al. · Genes Open access 31 Jul 2021 73
15 Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies Shelley E. Hancock, Chen-rei Wan, Nathan E. Fisher et al. · Expert Opinion on Drug Delivery Open access 3 Jan 2021 71
16 Suprachoroidal Triamcinolone Acetonide for Diabetic Macular Edema Charles C. Wykoff, Rahul N. Khurana, Shaun I.R. Lampen et al. · Ophthalmology Retina 4 May 2018 65
17 Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases Chen-rei Wan, Leroy W. Muya, Viral S. Kansara et al. · Pharmaceutics Open access 22 Feb 2021 62
18 Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy Andrew J. Lloyd, Natalia Piglowska, Thomas A. Ciulla et al. · British Journal of Ophthalmology Open access 18 Jan 2019 61
19 Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema Mark Barakat, Charles C. Wykoff, Víctor H. González et al. · Ophthalmology Retina Open access 20 Aug 2020 57
20 Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion Alex S. Willoughby, Vivian S. Vuong, David Cunefare et al. · American Journal of Ophthalmology Open access 2 Dec 2017 57
21 Anti-integrin therapy for retinovascular diseases Ashay Dilip Bhatwadekar, Viral S. Kansara, Qianyi Luo et al. · Expert Opinion on Investigational Drugs Open access 13 Jul 2020 56
22 Phosphorodiamidates as a Promising New Phosphate Prodrug Motif for Antiviral Drug Discovery: Application to Anti-HCV Agents Christopher McGuigan et al. · Journal of Medicinal Chemistry 31 Oct 2011 54
23 Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes Sook Hyun Chung, Iris Natalie Mollhoff, Alaknanda Mishra et al. · Human Gene Therapy Open access 15 Jan 2021 53
24 BRAMA: A New Graphic Animation Tool for B Models Thierry Servat · Lecture notes in computer science Conference paper 2006 52
25 Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA) Rahul N. Khurana, Pauline Townsend Merrill, Steven Yeh et al. · British Journal of Ophthalmology Open access 12 Mar 2021 48
26 Disease progression pathways of wet AMD: opportunities for new target discovery Amber T. Wolf, Alon Harris, Francesco Oddone et al. · Expert Opinion on Therapeutic Targets Open access 2 Jan 2022 47
27 The complement system: a novel therapeutic target for age-related macular degeneration Aumer Shughoury, Duriye Damla Sevgi, Thomas A. Ciulla · Expert Opinion on Pharmacotherapy 11 Sep 2023 46
28 The evolving therapeutic landscape of diabetic retinopathy Aumer Shughoury, Ashay Dilip Bhatwadekar, Denis Jusufbegovic et al. · Expert Opinion on Biological Therapy Open access 14 Aug 2023 43
29 RNA therapeutics for retinal diseases Michael C. Gemayel, Ashay Dilip Bhatwadekar, Thomas A. Ciulla · Expert Opinion on Biological Therapy Open access 14 Dec 2020 41
30 Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA) Christopher Ryan Henry, Milan Shah, Mark Barakat et al. · British Journal of Ophthalmology Open access 5 Feb 2021 40
31 Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema Shaun I.R. Lampen, Rahul N. Khurana, Glenn Noronha et al. · Ophthalmic surgery, lasers & imaging retina Sep 2018 39
32 Molecular Genetic Mechanisms in Age-Related Macular Degeneration Aumer Shughoury, Duriye Damla Sevgi, Thomas A. Ciulla · Genes Open access 12 Jul 2022 38
33 Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders Chen-rei Wan, Barry M. Kapik, Charles C. Wykoff et al. · Translational Vision Science & Technology Open access 22 Oct 2020 38
34 Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema Thomas A. Ciulla, Barry M. Kapik, Dilraj Singh Grewal et al. · Ophthalmology Retina Open access 30 Oct 2020 35
35 Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina Leroy W. Muya, Viral S. Kansara, Megan E. Cavet et al. · Journal of Ocular Pharmacology and Therapeutics Open access 11 Apr 2022 33
36 Microinjection via the suprachoroidal space: a review of a novel mode of administration Thomas A. Ciulla · The American Journal of Managed Care Open access Nov 2022 32
37 A Smart Mobile Application to Monitor Visual Function in Diabetic Retinopathy and Age-Related Macular Degeneration: The CLEAR Study Rahul N. Khurana, Carol Hoang, Arshad M. Khanani et al. · American Journal of Ophthalmology Open access 5 Apr 2021 31
38 Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits Viral S. Kansara, Leroy W. Muya, Thomas A. Ciulla · Translational Vision Science & Technology Open access 15 Jun 2021 28
39 Intraocular Distribution and Targeting of Triamcinolone Acetonide Suspension Administered Into the Suprachoroidal Space Henry F. Edelhauser, Rozemarijn S Verhoeven, Brian E. Burke et al. · Investigative Ophthalmology & Visual Science 30 Apr 2014 26
40 Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions Viral S. Kansara, Shelley E. Hancock, Leroy W. Muya et al. · Journal of Controlled Release Open access Sep 2022 25
41 Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment Ashay Dilip Bhatwadekar, Viral S. Kansara, Thomas A. Ciulla · Expert Opinion on Investigational Drugs Open access 27 Jan 2020 25
42 Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits Viral S. Kansara, Mark J. Cooper, Ozge Sesenoglu‐Laird et al. · Translational Vision Science & Technology Open access 15 Dec 2020 24
43 A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration Stephen H. Poor, Georges Weissgerber, Christopher M. Adams et al. · American Journal of Ophthalmology Open access 2 Mar 2022 21
44 Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion Thomas A. Ciulla, Barry M. Kapik, Allen Y. H. Hu et al. · Ophthalmology Retina Open access 30 Jun 2022 20
45 Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases Thiran Jayasundera, Rebhi Abuzaitoun, Gabrielle D. Lacy et al. · American Journal of Ophthalmology Open access 22 Aug 2021 20
46 Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial Mark Barakat, David M. Brown, Allen Hu et al. · Ophthalmology Science Open access 25 Jul 2024 18
47 Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema Thomas A. Ciulla, Barry M. Kapik, Mark Barakat et al. · American Journal of Ophthalmology Open access 2 Nov 2021 18
48 Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE Michael A. Singer, Pauline Townsend Merrill, Steven Yeh et al. · Clinical and Experimental Ophthalmology Open access 6 Nov 2021 18
49 Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial Pauline Townsend Merrill, Christopher Ryan Henry, Quan Dong Nguyen et al. · Ocular Immunology and Inflammation Open access 18 Aug 2021 18
50 Synchronous fluorescence spectroscopy of dissolved organic matter in surface waters: Application to airborne remote sensing Anthony Vodacek · Remote Sensing of Environment Dec 1989 18

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.